Detalhe da pesquisa
1.
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
Osteoporos Int
; 2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38587674
2.
Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
Osteoporos Int
; 34(12): 2121-2132, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37653346
3.
The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors.
Osteoporos Int
; 33(3): 527-540, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35048200
4.
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan.
Osteoporos Int
; 32(10): 2011-2021, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33772328
5.
Harmonization of commercial assays for PINP; the way forward.
Osteoporos Int
; 31(3): 409-412, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31975180
6.
Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.
Osteoporos Int
; 31(7): 1283-1290, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32020264
7.
Fracture risk following intermission of osteoporosis therapy.
Osteoporos Int
; 30(9): 1733-1743, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31175404
8.
Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.
Osteoporos Int
; 30(1): 45-57, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30382319
9.
Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.
Osteoporos Int
; 29(3): 557-566, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29230511
10.
Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement.
Osteoporos Int
; 33(8): 1641-1642, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35414136
11.
Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
Osteoporos Int
; 28(1): 413-417, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27766369
12.
Self-perception of fracture risk: what can it tell us?
Osteoporos Int
; 28(12): 3495-3500, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28861636
13.
International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
Osteoporos Int
; 28(3): 767-774, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28093634
14.
Wall suction-assisted image-guided thoracentesis: a safe alternative to evacuated bottles.
Clin Radiol
; 72(10): 898.e1-898.e5, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28554579
15.
Breath-hold PET/CT-guided tumour ablation under general anaesthesia: accuracy of tumour image registration and projected ablation zone overlap.
Clin Radiol
; 72(3): 223-229, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27889091
16.
Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
Osteoporos Int
; 27(7): 2197-2206, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27112766
17.
Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.
Osteoporos Int
; 27(1): 75-80, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26174879
18.
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.
Osteoporos Int
; 26(1): 361-72, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25236877
19.
Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
Oral Dis
; 21(7): 879-85, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26173924
20.
Development of the Osteoporosis Assessment Questionnaire--physical Function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function.
Osteoporos Int
; 25(2): 579-88, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23929004